ESPE Abstracts (2022) 95 P2-288

ESPE2022 Poster Category 2 Thyroid (22 abstracts)

Case Report: the rare case of pediatric myxedema due to an unrecognized chronic autoimmune hypothyroidism

Elisa Bonino 1,2,3 , Patrizia Matarazzo 1,2 , Raffaele Buganza 1,2 , Gerdi Tuli 1,2 , Jessica Munarin 1,2,3 , Claudia Bondone 4 & Luisa de Sanctis 1,2

1Department of Pediatric Endocrinology, Regina Margherita Children’s Hospital – Città della Salute e della Scienza, Turin, Italy; 2Department of Public Health and Pediatric Sciences, University of Turin, Regina Margherita Children’s Hospital, Turin, Italy; 3Postgraduate School of Pediatrics, University of Turin, Turin, Italy; 4Department of Pediatric Emergency, Regina Margherita Children’s Hospital – Città della Salute e della Scienza, Turin, Italy

Hypothyroidism is the most common thyroid disorder in children. It usually presents with nonspecific symptoms, that can be mild and occur slowly over time, compromising a timely diagnosis, with possible effects on pituitary gland, multiple organs and growth. In case of long-standing unrecognized hypothyroidism, myxedema or myxedema coma can occur, rare but severe conditions. This case report describes an adolescent presenting with extensive trunk and neck swelling. After excluding the main renal, gastrointestinal, and cardiac causes of edema, the ultrasound study showed a thickening of subcutaneous tissue and an enlarged thyroid, with ultrasound signs of thyroiditis. Blood exams showed extremely low FT4 concentrations (0.6 pg/ml), markedly increased TSH (>1000 IU/ml) and positive anti-thyroid peroxidase and anti-thyroglobulin antibodies. The condition was consistent with myxedema due to chronic autoimmune hypothyroidism. Other associated symptoms appeared mild, but significant neglected growth delay was present. Pituitary hyperplasia, hyperprolactinemia, increased serum creatinine and pericardial effusion were found. A prompt levothyroxine treatment allowed to reach an improvement of clinical status and edema regression in 2 weeks, a normalization of FT4 in 3 weeks and of TSH and creatinine in 2 months. Furthermore, Magnetic Resonance Imaging control at 6 months showed a complete regression of pituitary hyperplasia. Ongoing endocrinological follow-up will monitor growth, although current height and pubertal stage suggest a possibly compromised final height. The diagnostic delay could be linked to the apparent good health of the boy, not requiring pediatric evaluations, and to the underestimation of the growth delay, in presence of a family history of pubertal delay. This report suggests the importance of pediatric follow-up in adolescence, a critical period for identifying endocrine conditions which, if not diagnosed, can lead to severe clinical manifestations and even long-term sequelae.

Volume 95

60th Annual ESPE (ESPE 2022)

Rome, Italy
15 Sep 2022 - 17 Sep 2022

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.